LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes
- PMID: 38285739
- DOI: 10.1161/CIRCULATIONAHA.123.067241
LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes
Keywords: Editorials; homozygous familial hypercholesterolemia; hypercholesterolemia.
Conflict of interest statement
Comment on
-
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.Circulation. 2024 Jan 30;149(5):354-362. doi: 10.1161/CIRCULATIONAHA.122.063460. Epub 2023 Oct 18. Circulation. 2024. PMID: 37850379 Free PMC article. Clinical Trial.
-
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.Circulation. 2024 Jan 30;149(5):343-353. doi: 10.1161/CIRCULATIONAHA.123.065529. Epub 2023 Oct 20. Circulation. 2024. PMID: 37860863 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
